Company intelligence / Profile preview

Acmex Bio-Technology

Chongqing, Chongqing, Chinaacmexbio.com ↗

Ownership: Private
Development stage: Commercial

Overview

Acmex Bio-Technology is a commercial-stage biotech specializing in the development and manufacture of rapid diagnostic tests for fertility, infectious diseases, cardiac markers, tumor markers, drugs of abuse screening, food safety & GMO testing. Their products are CE-marked for global distribution; no clinical trial results are published as they focus on diagnostics rather than therapeutics.

Therapeutic areas: Infectious DiseasesCardiovascularOncologyWomen's Health
Modalities: Monoclonal antibodyRecombinant proteinDiagnostic reagent
Industry: Protein Biomarker Diagnostics

Partnerships

Collaborates with domestic universities/research institutions in China for R&D projectsGlobal distribution partners

Beyond the preview

Go deeper on Acmex Bio-Technology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Acmex Bio-Technology.

Explore the full profile